Novel, non-invasive markers for detecting therapy induced neuroendocrine differentiation in castration-resistant prostate cancer patients

Neuroendocrine prostate cancer (NEPC), a highly aggressive variant of castration-resistant prostate cancer (CRPC), often emerges upon treatment with androgen pathway inhibitors, via neuroendocrine differentiation. Currently, NEPC diagnosis is challenging as available markers are not sufficiently spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhagirath, Divya, Liston, Michael, Akoto, Theresa, Lui, Byron, Bensing, Barbara A., Sharma, Ashok, Saini, Sharanjot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050049/
https://www.ncbi.nlm.nih.gov/pubmed/33859239
http://dx.doi.org/10.1038/s41598-021-87441-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050049/
https://www.ncbi.nlm.nih.gov/pubmed/33859239
http://dx.doi.org/10.1038/s41598-021-87441-2

Ejemplares similares